Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease (Q35999630)

11 August 2017

Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease (English)

1 reference

11 August 2017

9

Gail P Jarvik

0 references

author name string

Daniel S Kim

1

1 reference

11 August 2017

Amber A Burt

2

1 reference

11 August 2017

Jane E Ranchalis

3

1 reference

11 August 2017

Rebecca J Richter

4

1 reference

11 August 2017

Julieann K Marshall

5

1 reference

11 August 2017

Jason F Eintracht

6

1 reference

11 August 2017

Elisabeth A Rosenthal

7

1 reference

11 August 2017

Clement E Furlong

8

1 reference

11 August 2017

language of work or name

1 reference

22 May 2012

1 reference

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

476316

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

The human paraoxonase gene cluster as a target in the treatment of atherosclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase (PON1 and PON3) Polymorphisms: Impact on Liver Expression and Atorvastatin-Lactone Hydrolysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Human PON1, a biomarker of risk of disease and exposure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase 1 status as a risk factor for disease or exposure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Determination of paraoxonase 1 status without the use of toxic organophosphate substrates

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase 1 (PON1) status and substrate hydrolysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

A long and winding road: defining the biological role and clinical importance of paraoxonases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Association study of detoxification genes in age related macular degeneration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase and coronary heart disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Polymorphisms in the human paraoxonase (PON1) promoter

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Inference of population structure using multilocus genotype data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Genetic association study of age-related macular degeneration in the Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Vitamin C and E intake is associated with increased paraoxonase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F476316

PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364586

Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein

23 September 2018

1 reference

12 December 2020

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

12 December 2020

Multiple QTLs influence variation in paraoxonase 1 activity in Mexican Americans

1 reference

12 December 2020

Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: a meta-analysis

1 reference

12 December 2020

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

12 December 2020

Favorable Effect of Short-Term Lifestyle Intervention on Human Paraoxonase-1 Activity and Adipokine Levels in Childhood Obesity

1 reference

12 December 2020

Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus

1 reference

12 December 2020

Paraoxonase-1 is a major determinant of clopidogrel efficacy

1 reference

12 December 2020

Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein

1 reference

12 December 2020

Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease

1 reference

12 December 2020

Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus

1 reference

12 December 2020

MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study

1 reference

12 December 2020

Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/476316

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22685667

1 reference